Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- ESCIKCIScopus
- 저널 순위
- Scopus Q1KCI Q1
- 저널
- Clinical and Experimental Pediatrics64(12) · pp.602 · 2021
- 피인용
- Scopus 6KCI 0
- FWCI (Scopus)
- 0.67
- ISSN
- 2713-4148
저자
- Cho, Hye-Kyung제1저자Department of Pediatrics, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- 박수은Department of Pediatrics, School of Medicine, Pusan National University, Pusan, Korea
- Kim, Yae-JeanDepartment of Pediatrics, Sungkyunkwan University School of Medicine, Suwon, Korea
- Jo, Dae SunDepartment of Pediatrics, Jeonbuk National University Medical School, Jeonju, Korea
- Kim, Yun-KyungDepartment of Pediatrics, Korea University College of Medicine, Seoul, Korea
- Eun, Byung-WookDepartment of Pediatrics, School of Medicine, Eulji University, Daejeon, Korea
- Lee, Taek-JinDepartment of Pediatrics, CHA University School of Medicine, Pocheon, Korea
- Lee, JinaDepartment of Pediatrics, University of Ulsan College of Medicine, Ulsan, Korea
- Lee, HyunjuDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
- Kim, Ki Hwan교신저자Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea
- Cho, Eun YoungDepartment of Pediatrics, Chungnam National University School of Medicine, Daejeon, Korea
- Ahn, Jong GyunDepartment of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea
- Choi, Eun HwaDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
초록
© 2021 by The Korean Pediatric Society.In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTaP-IPV-Hib-HepB (Hexaxim, Sanofi Pasteur), for use as a 3-dose primary series in infants aged 2, 4, and 6 months. The DTaP-IPV-Hib-HepB vaccine is highly immunogenic and safe and provides a long-term immune response based on studies performed in a variety of settings in many countries, including Korea. This report summarizes the Committee on Infectious Diseases of the Korean Pediatric Society guidelines for the use of this newly introduced hexavalent combination vaccine.
키워드
CombinedDiphtheria-tetanus-acellular pertussis-inactivateInfantVaccines
식별자
- Scopus EID
- 2-s2.0-85124351583
- KCI
- ART002785655



로그인
연구물 목록으로